Combination therapy with diuretics: an evolution of understanding (Q41171825)

27 September 2017

1 reference

title

Combination therapy with diuretics: an evolution of understanding (English)

1 reference

27 September 2017

J M Neutel

1

1 reference

27 September 2017

H R Black

series ordinal

2

1 reference

27 September 2017

M A Weber

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

American Journal of Medicine

27 September 2017

1 reference

27 September 2017

101

1 reference

27 September 2017

61S-70S

1 reference

27 September 2017

3A

1 reference

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Angiotensin-converting enzyme inhibitors in the treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Regulation of sodium balance in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Long-term effect of nifedipine and hydrochlorothiazide on blood pressure and sodium homeostasis at varying levels of salt intake in mildly hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Calcium entry blockers in the treatment of hypertension. Current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

The antihypertensive effect of verapamil at extremes of dietary sodium intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Dietary sodium and the antihypertensive effect of nifedipine in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

A double-blind crossover study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

The combination of chlorthalidone with nifedipine does not exert an additive antihypertensive effect in essential hypertensives: a crossover multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Hemodynamic interactions between diuretics and calcium antagonists in the treatment of hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Mild hypertension in the elderly. A comparison of prazosin and enalapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Effects of enalapril alone, and in combination with hydrochlorothiazide, on renin-angiotensin-aldosterone, renal function, salt and water excretion, and body fluid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistent to enalapril monotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Combination antihypertensive therapy with terazosin and other antihypertensive agents: Results of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Captopril and atenolol combined with hydrochlorothiazide in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Captopril in combination with hydrochlorothiazide: comparative efficacy vs perceived best therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Once vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: a double-blind crossover study in known responders to a standard combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Captopril plus hydrochlorothiazide once daily normalizes 24 h blood pressure in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Metabolic effects of the combination of captopril and hydrochlorothiazide in hypertensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Comparison of once and twice daily administration of captopril plus hydrochlorothiazide on 24 h blood pressure levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Captopril and hydrochlorothiazide in the fixed combination multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Determination of the optimal dosage regimen of captopril + hydrochlorothiazide in the treatment of moderate arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Efficacy and tolerability of a fixed combination of metoprolol CR/ZOK 100 mg and hydrochlorothiazide (HCT) 12.5 mg in comparison with the fixed combination of metoprolol and HCT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

A double-blind comparison of felodipine and hydrochlorothiazide added to metoprolol to control hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900269-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(96)00269-0

1 reference

27 September 2017

1 reference